Junli He
CEO, Director · Harvard Apparatus Regenerative Technology, Inc.
IndividualBuying only
- 2025
- Sep 25, 2026
- 6
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Junli He's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Junli He?
Junli He is a corporate insider, tracked as CEO, Director of Harvard Apparatus Regenerative Technology, Inc. (HRGN). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Junli He submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Junli He been buying or selling stock?
Recorded transactions: 6 open-market purchases ($428K) and 0 open-market sales across all tracked filings.
